This inventor holds 2 USPTO granted patents and 4 published patent applications and 1 EPO patent. Top assignee: Maze Therapeutics, Inc.. Active years: 2024-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024-2025
Title: The Innovative Contributions of Sarah M Bronner
Introduction
Sarah M Bronner is a prominent inventor based in Oakland, CA, known for her significant contributions to the field of biotechnology. With a focus on developing innovative solutions for medical challenges, she has made strides in the area of APOL1 inhibitors.
Latest Patents
Sarah holds 2 patents, with her latest inventions centered around APOL1 inhibitors and methods of use. These patents detail compounds of formula (II) and include methods for preparing these compounds, as well as techniques for inhibiting APOL1. Her work aims to address APOL1-mediated diseases, disorders, or conditions, providing potential therapeutic avenues for affected individuals.
Career Highlights
Currently, Sarah is associated with Maze Therapeutics, Inc., where she continues to push the boundaries of innovation in her field. Her expertise and dedication have positioned her as a key player in the development of novel therapeutic strategies.
Collaborations
Throughout her career, Sarah has collaborated with notable colleagues, including Patrick Sang Tae Lee and Todd Jonathan August Ewing. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Sarah M Bronner's work exemplifies the spirit of innovation in biotechnology, particularly through her advancements in APOL1 inhibitors. Her contributions are paving the way for new treatments and improving the lives of many individuals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile